Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the cooperativity of PROTAC-induced ternary complexes using 19F NMR displacement assay
Guilherme V. Castro, Alessio Ciulli
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1765-1770
Open Access | Times Cited: 13

Showing 13 citing articles:

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
Claudia J. Diehl, Alessio Ciulli
Chemical Society Reviews (2022) Vol. 51, Iss. 19, pp. 8216-8257
Open Access | Times Cited: 124
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167569-167569
Open Access | Times Cited: 47
Affinity measurement of strong ligands with NMR spectroscopy: Limitations and ways to overcome them
Claudio Dalvit, Isabel Gmür, Philip Rößler, et al.
Progress in Nuclear Magnetic Resonance Spectroscopy (2023) Vol. 138-139, pp. 52-69
Open Access | Times Cited: 34
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 29
Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research
Janet Caceres‐Cortes, Bradley T. Falk, Luciano Mueller, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1701-1733
Closed Access | Times Cited: 6
Breaking free from the crystal lattice: Structural biology in solution to study protein degraders
Kevin Haubrich, Valentina A. Spiteri, William Farnaby, et al.
Current Opinion in Structural Biology (2023) Vol. 79, pp. 102534-102534
Open Access | Times Cited: 10
Advancing target validation with PROTAC technology
Margaret Spitz, Aseel Kashkush, Raphael I. Benhamou
Expert Opinion on Drug Discovery (2025)
Closed Access
A Fragment‐Based Competitive 19F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling
William J. McCarthy, S.E. Thomas, Tayo Olaleye, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 37
Open Access | Times Cited: 1
Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673
Yue Wu, Bernd Meibohm, Taichang Zhang, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
Qingxin Li, CongBao Kang
Molecules (2024) Vol. 29, Iss. 23, pp. 5748-5748
Open Access | Times Cited: 1
A Fragment‐Based Competitive 19F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling
William J. McCarthy, S.E. Thomas, Tayo Olaleye, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 37
Open Access
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Sven A. Miller, Grigorii Andrianov, Victoria Mischley, et al.
(2022), pp. 151-176
Closed Access | Times Cited: 1
A Structural and Biophysical Perspective of Degrader Activity Through Ternary Complex Formation
Morgan S. Gadd, Marine C. Aublette
(2022), pp. 107-149
Closed Access
Page 1

Scroll to top